Modulation of Equid Herpesvirus-1 Replication Dynamics In Vitro Using CRISPR/Cas9-Assisted Genome Editing
Viruses · 2024
DOI: 10.3390/v16030409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Rabab T Hassanien und 4 weiteren Autor:innen. Beteiligte Einrichtung: Louisiana Animal Disease Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA. Hauptthemen laut MEDLINE: Gene Editing, Herpesvirus 1, Equid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: USAID (Higher Education Initiative, Graduate Scholarships for Professional [GSP]), USAID GSP and self-generated research funds.
Abstract (Originalsprache)
(1) Background: equid alphaherpesvirus-1 (EHV-1) is a highly contagious viral pathogen prevalent in most horse populations worldwide. Genome-editing technologies such as CRISPR/Cas9 have become powerful tools for precise RNA-guided genome modifications; (2) Methods: we designed single guide RNAs (sgRNA) to target three essential (ORF30, ORF31, and ORF7) and one non-essential (ORF74) EHV-1 genes and determine their effect on viral replication dynamics in vitro; (3) Results: we demonstrated that sgRNAs targeting essential lytic genes reduced EHV-1 replication, whereas those targeting ORF74 had a negligible effect. The sgRNAs targeting ORF30 showed the strongest effect on the suppression of EHV-1 replication, with a reduction in viral genomic copy numbers and infectious progeny virus output. Next-generation sequencing identified variants with deletions in the specific cleavage site of selective sgRNAs. Moreover, we evaluated the combination between different sgRNAs and found that the dual combination of sgRNAs targeting ORF30 and ORF7 significantly suppressed viral replication to lower levels compared to the use of a single sgRNA, suggesting a synergic effect; (4) Conclusion: data demonstrate that sgRNA-guided CRISPR/Cas9 can be used to inhibit EHV-1 replication in vitro, indicating that this programmable technique can be used to develop a novel, safe, and efficacious therapeutic and prophylactic approach against EHV-1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Louisiana Animal Disease Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
- Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
- Virology Department, Animal Health Research Institute, Agriculture Research Center (ARC), Dokki, Giza 12618, Egypt.
- Department of Veterinary Diagnostics and Production Animal Medicine, Iowa State University, Ames, IA 50011, USA.
ORCID-Profile: Rabab T Hassanien, Côme J Thieulent, Mariano Carossino, Udeni B R Balasuriya
Förderung
- USAID (Higher Education Initiative, Graduate Scholarships for Professional [GSP])
- USAID GSP and self-generated research funds
Zitieren
APA
Hassanien, R. T., Thieulent, C. J., Carossino, M., Li, G., & Balasuriya, U. B. R. (2024). Modulation of Equid Herpesvirus-1 Replication Dynamics In Vitro Using CRISPR/Cas9-Assisted Genome Editing. Viruses. https://doi.org/10.3390/v16030409
Vancouver
Hassanien RT, Thieulent CJ, Carossino M, Li G, Balasuriya UBR. Modulation of Equid Herpesvirus-1 Replication Dynamics In Vitro Using CRISPR/Cas9-Assisted Genome Editing. Viruses. 2024. doi:10.3390/v16030409
BibTeX
@article{Hassanien2024,
author = {Hassanien, Rabab T and Thieulent, Côme J and Carossino, Mariano and Li, Ganwu and Balasuriya, Udeni B R},
title = {Modulation of Equid Herpesvirus-1 Replication Dynamics In Vitro Using CRISPR/Cas9-Assisted Genome Editing},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16030409}
}
EUVIMED